Middle East Africa Direct-to-Consumer Laboratory Testing Market: Introduction
According to the report, the direct-to-consumer laboratory testing market in MEA was valued at US$ 124.40 Mn in 2020 and is projected to expand at a CAGR of 18.3% from 2021 to 2031. Direct-to-consumer laboratory testing, also known as direct access testing, allows patients to order tests directly from a lab without having to go through a healthcare professional. These test results can be used to track a current health condition, diagnose a previously undiagnosed medical condition, or provide information on personal health traits.
In line with the rise in demand for quick, affordable, and accurate tests, several companies have considered offering actionable recommendations to complement the test results. This approach induces the customer to seek personalized services and maximizes customer satisfaction. This is anticipated to propel the market during the forecast period from 2021 to 2031.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=Brep_id=83925
Rest of MEA held major share of the direct-to-consumer laboratory testing market in MEA in 2020, due to increase in government regulations, technological advancements, rise in awareness among people, and surge in the geriatric population.
Genetic Testing Dominated Middle East Africa Direct-to-Consumer Laboratory Testing Market
In terms of test type, the direct-to-consumer laboratory testing market in MEA has been classified into genetic testing, disease risk assessment testing, CBC, chronic disease testing, COVID-19 testing, TSH testing, and others. The genetic testing segment has been split into nutrigenetics test, celiac disease test, sports physical activity testing, men's health tests, women's health tests, pregnancy prenatal screening, general health testing, and others.
Request Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=Srep_id=83925
The nutrigenetics test sub-segment has been segregated into weight control, lactose intolerance, and others. The disease risk assessment testing segment has been classified into sexual health tests, cancer predisposition tests, and others. The sexual health tests sub-segment has been split into HIV, chlamydia, and others. The chronic disease testing segment has been split into diabetes testing, hypertension, and others. The genetic testing segment dominated the direct-to-consumer laboratory testing market in MEA in 2020, and the trend is projected to continue during the forecast period.
Saliva Sample Type Held Major Market Share
Based on sample type, the direct-to-consumer laboratory testing market in MEA has been categorized into blood, saliva, urine, and others. The saliva segment held major share of the direct-to-consumer laboratory testing market in MEA in 2020.
Get COVID-19 Analysis on Middle East Africa Direct-to-Consumer Laboratory Testing Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19rep_id=83925
Diagnostic Centers Emerge as Key Providers of Direct-to-Consumer Laboratory Tests
In terms of provider, the direct-to-consumer laboratory testing market in MEA has been divided into hospitals, clinics, specialty labs, and diagnostic centers. The diagnostic centers segment dominated the direct-to-consumer laboratory testing market in MEA during the forecast period.
Rest of MEA to Lead Market
In terms of country/sub-region, the direct-to-consumer laboratory testing market in MEA has been segmented into GCC Countries, South Africa, and Rest of MEA. Rest of MEA is anticipated to account for a leading share of the direct-to-consumer laboratory testing market in MEA during the forecast period.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EBrep_id=83925
Growth Strategies of Key Players
Key players operating in the direct-to-consumer laboratory testing market in MEA are 23andMe, Inc., Ancestry, CircleDNA, Eurofins Scientific, Family Tree DNA (Gene by Gene), Laboratory Corporation of America Holdings, Living DNA Ltd., Medichecks.com Ltd., MyHeritage Ltd., MyMedLab, Inc., and Quest Diagnostics Incorporated. The direct-to-consumer laboratory testing market in MEA is consolidated with the presence of international and local players.
More Trending Reports by Transparency Market Research –
Sepsis Treatment Market:
Shizophrenia Drugs Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
